Biltmore Family Office LLC Sells 996 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Biltmore Family Office LLC trimmed its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 5.2% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 18,160 shares of the exchange traded fund’s stock after selling 996 shares during the period. Biltmore Family Office LLC’s holdings in SPDR S&P Biotech ETF were worth $1,635,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of the company. Kohmann Bosshard Financial Services LLC bought a new stake in SPDR S&P Biotech ETF during the fourth quarter valued at about $29,000. Golden State Wealth Management LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter worth $29,000. Avior Wealth Management LLC raised its stake in SPDR S&P Biotech ETF by 393.6% in the fourth quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after buying an additional 307 shares in the last quarter. Lee Danner & Bass Inc. bought a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter valued at about $38,000. Finally, Bank of Jackson Hole Trust purchased a new stake in SPDR S&P Biotech ETF in the fourth quarter valued at about $43,000.

SPDR S&P Biotech ETF Stock Up 3.1 %

Shares of NYSEARCA:XBI opened at $80.59 on Thursday. The business has a 50-day moving average price of $88.81 and a 200-day moving average price of $93.53. The stock has a market cap of $5.08 billion, a price-to-earnings ratio of 11.47 and a beta of 1.00. SPDR S&P Biotech ETF has a 52-week low of $77.26 and a 52-week high of $105.47.

SPDR S&P Biotech ETF Cuts Dividend

The business also recently declared a dividend, which was paid on Wednesday, March 26th. Investors of record on Monday, March 24th were issued a $0.0053 dividend. The ex-dividend date of this dividend was Monday, March 24th.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.